GILD
Gilead Sciences is a biopharmaceutical company focused on discovering, developing, and delivering medicines across virology, oncology, and inflammation to improve global health. The company emphasizes HIV, viral hepatitis, liver disease, cancer, and inflammatory conditions, with a pipeline spanning multiple therapeutic areas and a global presence. It highlights investments in research, patient access, and responsible corporate initiatives to advance health equity worldwide. Headquartered in Foster City, California, Gilead operates internationally to bring breakthrough therapies to patients around the world.